Biotech

Opening bell: Myesha Lacy of Arcellx on the biotech’s IPO

Jun 15, 2022

‘Why are you going public now?’ asked investors during biotech Arcellx’s IPO in early February this year. It was not a surprising...Read more

Feb 16, 2022

Many US biotechs have ‘limited or no explicit ESG disclosure’ despite recognizing the growing importance of sustainability to...Read more

Nov 17, 2021

Courtney Dugan has been named vice president of investor relations, public relations and corporate communications at Cambridge,...Read more

Jun 08, 2021

Sponsored content For companies in the biotech sector, 2021 is off to a fast start as capital-raising among new issuers...Read more

Jan 25, 2019

The UK biotech sector was given a massive boost last year when it raised a record £2.2 bn ($2.9 bn) from investors. New figures in a...Read more